Regulation of transcription factor function by purinergic signalling in cardiovascular diseases

Area of Science:

• Biomedical Science
• Molecular Biology
• Cardiology

Background:

• Cardiovascular diseases (CVDs) are the leading global cause of mortality.
• Transcription factors are key regulators in CVD pathophysiology, influencing inflammation, oxidative stress, angiogenesis, and metabolism.
• Purinergic signaling pathways are critical regulators of hemostasis in both health and disease.

Purpose of the Study:

• To summarize the roles and mechanisms of transcription factors regulated by purinergic pathways in various CVDs.
• To highlight the interplay between purinergic signaling and transcription factor networks in CVD pathogenesis.
• To provide insights for novel therapeutic and preventive strategies against CVDs.

Main Methods:

• Literature review and synthesis of existing research on purinergic signaling and transcription factors in CVDs.
• Analysis of molecular mechanisms linking purinergic substances to transcription factor activity.
• Examination of the involvement of these pathways across different types of cardiovascular diseases.

Main Results:

• Purinergic signaling modulates transcription factors involved in key CVD processes like inflammation and oxidative stress.
• Specific transcription factors regulated by purinergic pathways have been identified in conditions such as hypertension, atherosclerosis, myocardial ischemia, and infarction.
• These interactions form complex signaling networks contributing to CVD development.

Conclusions:

• Transcription factors regulated by purinergic pathways are integral to the pathophysiology of cardiovascular diseases.
• Targeting these purinergic-regulated transcription factors presents a promising strategy for developing novel CVD treatments.
• Further research into these mechanisms is essential for advancing CVD prevention and management.